Retension Pharmaceuticals, Inc. (RTSN) stock analysis
RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.27+0.02 (+0.16%)
Close on Nov 13, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Retension Pharmaceuticals.
See a number that looks wrong?